<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03601559</url>
  </required_header>
  <id_info>
    <org_study_id>NH-03937</org_study_id>
    <nct_id>NCT03601559</nct_id>
  </id_info>
  <brief_title>The Cognitive Effects of 6 Weeks Administration With a Probiotic</brief_title>
  <official_title>The Cognitive Effects of 6 Weeks Administration With a Probiotic: a Randomized, Placebo Controlled Proof-of-concept Study in Healthy Elderly Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northumbria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>DuPont Nutrition and Health</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Northumbria University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the cognitive and mood effects of a probiotic&#xD;
      dietary supplement when taken daily for 42 days in healthy older adults aged 65+&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 31, 2018</start_date>
  <completion_date type="Actual">June 10, 2019</completion_date>
  <primary_completion_date type="Actual">June 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Episodic memory score</measure>
    <time_frame>6 weeks</time_frame>
    <description>This is a composite measure derived from summing the z score performance on the following cognitive tasks: immediate word recall, delayed word recall, delayed picture recognition, delayed word recognition (-4 to 4)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>STAI-state total score</measure>
    <time_frame>6 weeks</time_frame>
    <description>State-trait anxiety inventory 'state' total score (20-80)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STAI-trait total score</measure>
    <time_frame>6 weeks</time_frame>
    <description>State-trait anxiety inventory 'trait' total score (20-80)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of attention score</measure>
    <time_frame>6 weeks</time_frame>
    <description>This is a composite measure derived from summing the z score accuracy performance on the choice reaction time and Rapid visual information processing tasks (-2 to 2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speed of attention score</measure>
    <time_frame>6 weeks</time_frame>
    <description>This is a composite measure derived from summing the z score reaction times from the choice reaction time and Rapid visual information processing task (-2 to 2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Working memory score</measure>
    <time_frame>6 weeks</time_frame>
    <description>This is a composite measure derived from summing the z score accuracy performance on the numeric working memory task and Corsi block-tapping task (-2 to 2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speed of memory score</measure>
    <time_frame>6 weeks</time_frame>
    <description>This is a composite measure derived from summing the z score reaction times on the numeric working memory task, the delayed name / face recall task, the delayed picture recognition task and the delayed word recognition task (-4 to 4)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delayed word recall correct</measure>
    <time_frame>6 weeks</time_frame>
    <description>total number of correctly identified words (0-15)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delayed word recall errors</measure>
    <time_frame>6 weeks</time_frame>
    <description>total number of error responses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Picture recognition reaction time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Picture recognition accuracy</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Word recognition reaction time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Word recognition accuracy</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Name to Face Recall correct responses</measure>
    <time_frame>6 weeks</time_frame>
    <description>number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Name to Face Recall reaction time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peg and Ball task Planning time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peg and Ball task Completion time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peg and Ball task errors</measure>
    <time_frame>6 weeks</time_frame>
    <description>Number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroop task accuracy</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroop task reaction time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immediate word recall task correctly identified words</measure>
    <time_frame>6 weeks</time_frame>
    <description>total number (0-15)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immediate word recall task error responses</measure>
    <time_frame>6 weeks</time_frame>
    <description>total number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric working memory accuracy</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric working memory reaction time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Choice reaction time accuracy</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Choice reaction time reaction time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid visual information processing accuracy</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid visual information processing reaction time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid visual information processing false alarms</measure>
    <time_frame>6 weeks</time_frame>
    <description>number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corsi blocks accuracy</measure>
    <time_frame>6 weeks</time_frame>
    <description>Average scores from the last five correctly completed trials from the Corsi block-tapping task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid visual information processing accuracy</measure>
    <time_frame>6 weeks</time_frame>
    <description>(%) - calculated from the 3 cycles of the Cognitive Demand Battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid visual information processing reaction time</measure>
    <time_frame>6 weeks</time_frame>
    <description>(ms) - calculated from the 3 cycles of the Cognitive Demand Battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rapid visual information processing false alarms</measure>
    <time_frame>6 weeks</time_frame>
    <description>number - calculated from the 3 cycles of the Cognitive Demand Battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serial 3 subtractions total responses</measure>
    <time_frame>6 weeks</time_frame>
    <description>number- calculated from the 3 cycles of the Cognitive Demand Battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serial 3 subtractions total error responses</measure>
    <time_frame>6 weeks</time_frame>
    <description>number - calculated from the 3 cycles of the Cognitive Demand Battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serial 7 subtractions total responses</measure>
    <time_frame>6 weeks</time_frame>
    <description>number - calculated from the 3 cycles of the Cognitive Demand Battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serial 7 subtractions total error responses</measure>
    <time_frame>6 weeks</time_frame>
    <description>number - calculated from the 3 cycles of the Cognitive Demand Battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental fatigue</measure>
    <time_frame>6 weeks</time_frame>
    <description>visual analogue scale (%) - calculated from the 3 cycles of the Cognitive Demand Battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alertness</measure>
    <time_frame>6 weeks</time_frame>
    <description>visual analogue scale (%) - calculated from the 3 cycles of the Cognitive Demand Battery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alert</measure>
    <time_frame>6 weeks</time_frame>
    <description>derived from Bond Lader visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Content</measure>
    <time_frame>6 weeks</time_frame>
    <description>derived from Bond Lader visual analogue scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calm</measure>
    <time_frame>6 weeks</time_frame>
    <description>derived from Bond Lader visual analogue scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Cognitive Change</condition>
  <arm_group>
    <arm_group_label>Lactobacillus paracasei Lpc-37</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Probiotic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Inert placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus paracasei Lpc-37</intervention_name>
    <description>Live probiotic bacteria</description>
    <arm_group_label>Lactobacillus paracasei Lpc-37</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Inert placebo matched for taste and appearance</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female, aged â‰¥ 65 years&#xD;
&#xD;
          2. Willing and able to provide written and informed consent&#xD;
&#xD;
          3. Ability of the participant (in the Principal Investigator's opinion) to comprehend the&#xD;
             full nature and purpose of the study including possible risks and side effects&#xD;
&#xD;
          4. Agreement to comply with the protocol and study restrictions&#xD;
&#xD;
          5. Available for all study visits&#xD;
&#xD;
          6. In good general health, self-reported and as judged by the Principal&#xD;
             Investigator/Clinical advisor based on medical history&#xD;
&#xD;
          7. Fluent in written and spoken English&#xD;
&#xD;
          8. Participant is willing to maintain habitual diet (including caffeine and alcohol) and&#xD;
             physical activity patterns throughout the study period&#xD;
&#xD;
          9. Has a bank account (required for payment)&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. Have any pre-existing significant acute or chronic co-existing medical condition /&#xD;
             illness which contraindicates, in the Principal Investigator's judgement, entry to the&#xD;
             study NOTE: the explicit exceptions to this are controlled (medicated) hypertension,&#xD;
             arthritis, asthma, hay fever, high cholesterol and reflux-related conditions. There&#xD;
             may be other, unforeseen, exceptions and these will be considered on a case-by-case&#xD;
             basis; i.e. participants may be allowed to progess to screening if they have a&#xD;
             condition/illness which would not interact with the active treatments or impede&#xD;
             performance&#xD;
&#xD;
          2. History of dementia, stroke and other neurological conditions&#xD;
&#xD;
          3. Traumatic loss of consciousness in the last 12 months&#xD;
&#xD;
          4. History of epilepsy or Parkinson's disease&#xD;
&#xD;
          5. Anxiety, depression or any psychiatric disorder that the Principal Investigator&#xD;
             believes would interfere with the objectives of the study and requiring treatment in&#xD;
             the last 2 years&#xD;
&#xD;
          6. Currently taking (from day of screening onwards) or have previously taken (last 4&#xD;
             weeks prior to screening) prescription medications that the Principal Investigator&#xD;
             believes would interfere with the objectives of the study, pose a safety risk or&#xD;
             confound the interpretation of the study results such as psychoactive medication&#xD;
             (anxiolytics, sedatives, hypnotics, anti-psychotics, anti-depressants,&#xD;
             anti-convulsants, centrally acting corticosteroids, opioid pain relievers) NOTE: the&#xD;
             explicit exceptions to this are hormone replacement treatments for female participants&#xD;
             where symptoms are stable, those medications used in the treatment of arthritis, high&#xD;
             blood pressure, high cholesterol and reflux-related conditions; and those taken 'as&#xD;
             needed' in the treatment of asthma and hay fever. As above, there may be other&#xD;
             instances of medication use which, where no interaction with the active treatments is&#xD;
             likely, participants may be able to progress to screening&#xD;
&#xD;
          7. Currently taking (from day of screening onwards) medication or dietary supplements&#xD;
             that the Principal Investigator believes would interfere with the objectives of the&#xD;
             study, pose a safety risk or confound the interpretation of the study results such as:&#xD;
             melatonin, vitamin E, multivitamins, B vitamin complex, ginkgo biloba, fish oil, St.&#xD;
             John's Wort or other cognitive enhancing dietary or herbal supplements over the study&#xD;
             period&#xD;
&#xD;
          8. Recent (within last 4 weeks prior to screening) or ongoing antibiotic therapy during&#xD;
             the intervention period&#xD;
&#xD;
          9. Daily consumption of concentrated sources of probiotics and / or prebiotics within 2&#xD;
             weeks of screening and throughout the intervention period other than the provided&#xD;
             study products (e.g., probiotic / prebiotic tablets, capsules, drops or powders),&#xD;
             including yoghurt or yoghurt drinks&#xD;
&#xD;
         10. Have high blood pressure (systolic over 159 mm Hg or diastolic over 99 mm Hg)&#xD;
&#xD;
         11. Have a Body Mass Index (BMI) outside of the range 18.5-29.9 kg/m2&#xD;
&#xD;
         12. Have learning difficulties, dyslexia&#xD;
&#xD;
         13. Have a visual impairment that cannot be corrected with glasses or contact lenses&#xD;
             (including colour-blindness)&#xD;
&#xD;
         14. Current smoker (use of nicotine replacement products, vaping, gum, patches etc)&#xD;
&#xD;
         15. Have a history of alcohol or drug abuse&#xD;
&#xD;
         16. Current misuse of alcohol, drug or prescription medications&#xD;
&#xD;
         17. Excessive caffeine intake (&gt;500 mg per day)&#xD;
&#xD;
         18. Excessive alcohol consumption (drinking on 5 or more days a week or consuming &gt; 6&#xD;
             units of alcohol in a single session on 5 or more days a week) for 3 weeks prior to&#xD;
             screening and during the intervention period&#xD;
&#xD;
         19. Contraindication to any substance in the investigational product&#xD;
&#xD;
         20. Principal Investigator believes that the participant may be uncooperative and / or&#xD;
             noncompliant and should therefore not participate in the study&#xD;
&#xD;
         21. Participant under legal or administrative supervision&#xD;
&#xD;
         22. Have food intolerances / sensitivities&#xD;
&#xD;
         23. Have any health condition that would prevent fulfilment of the study requirements&#xD;
&#xD;
         24. Are unable or unwilling to complete all the study assessments&#xD;
&#xD;
         25. Are currently participating in other clinical or nutrition intervention studies, or&#xD;
             have in the past 4 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippa A Jackson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northumbria University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northumbria University</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <state>Tyne And Wear</state>
        <zip>NE1 8ST</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://nutrition-neuroscience.co.uk</url>
    <description>Link to study site website</description>
  </link>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>July 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>June 17, 2019</last_update_submitted>
  <last_update_submitted_qc>June 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gut-brain axis, cognitve demand battery, probiotics</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

